DrugPatentWatch Database Preview
CHLORAPREP ONE-STEP Drug Profile
Email this page to a colleague
» See Plans and PricingWhen do Chloraprep One-step patents expire, and when can generic versions of Chloraprep One-step launch?
Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. There are three patents protecting this drug.
This drug has twenty-three patent family members in twelve countries.
The generic ingredient in CHLORAPREP ONE-STEP is chlorhexidine gluconate; isopropyl alcohol. There are fifty-eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate; isopropyl alcohol profile page.
US ANDA Litigation and Generic Entry Outlook for Chloraprep One-step
Indicators of Generic Entry
Summary for CHLORAPREP ONE-STEP
| International Patents: | 23 |
| US Patents: | 3 |
| Applicants: | 1 |
| NDAs: | 2 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 34 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CHLORAPREP ONE-STEP at DailyMed |
Recent Clinical Trials for CHLORAPREP ONE-STEP
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Gebauer Company | Phase 4 |
| Henry Ford Health System | Phase 4 |
| University College, London | Phase 3 |
US Patents and Regulatory Information for CHLORAPREP ONE-STEP
Expired US Patents for CHLORAPREP ONE-STEP
International Patents for CHLORAPREP ONE-STEP
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Germany | 69728280 | Start Trial |
| Australia | 4249296 | Start Trial |
| Spain | 2159651 | Start Trial |
| Germany | 60126127 | Start Trial |
| Canada | 2263158 | Start Trial |
| European Patent Office | 3117866 | Start Trial |
| Start Trial | ||
| >Country | >Patent Number | >Estimated Expiration |
